rs768471577
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000441.2(SLC26A4):c.1337A>G(p.Gln446Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000378 in 1,612,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000758 AC: 19AN: 250738Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135466
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1459990Hom.: 0 Cov.: 30 AF XY: 0.0000578 AC XY: 42AN XY: 726406
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74348
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:3
The missense variant NM_000441.2(SLC26A4):c.1337A>G (p.Gln446Arg) has been reported in homozygous state in several families affected with hearing loss (PMID: 30303587, PMID: 19287372, PMID: 24949729). This variant is observed in 18/30616 (0.06%) alleles from individuals of South Asian background in the gnomAD database, but was not seen in the homozygous state. Computational prediction tools and conservation analysis indicate that this change is damaging to the protein. Published in vitro functional studies indicated that this variant leads to mis-localization of the protein and loss of pendrin iodide transport (PMID: 11932316). This variant has been confirmed to occur in trans (in a compound heterozygous state) with a second variant in the patient and his sibling. For these reasons, this variant has been classified as Pathogenic. -
- -
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000550505, PS1_S). Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 11932316, PS3_S).The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000076, PM2_M). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.914, 3CNET: 0.817, PP3_P). A missense variant is a common mechanism associated with Deafness (PP2_P). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
Pendred syndrome Pathogenic:2
- -
Variant summary: SLC26A4 c.1337A>G (p.Gln446Arg) results in a conservative amino acid change located in the SLC26A/SulP transporter domain (IPR011547) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.6e-05 in 250738 control chromosomes, predominantly at a frequency of 0.00059 within the South Asian subpopulation in the gnomAD database. This frequency is not higher than expected for a pathogenic variant in SLC26A4 causing Pendred Syndrome (0.00059 vs 0.0035), allowing no conclusion about variant significance. c.1337A>G has been reported in the literature in the homozygous or compound heterozygous state in multiple families affected with hearing loss (e.g. Taylor_2002, Rehman_2015, Naz_2017, Richard_2019). These data indicate that the variant is very likely to be associated with disease. Experimental evidence evaluating an impact on protein function demonstrated the variant failed to reach the cell membrane and colocalized with the endoplasmic reticulum, and had lost its ability to transport iodide (Taylor_2002). Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SLC26A4 function (PMID: 11932316). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A4 protein function. ClinVar contains an entry for this variant (Variation ID: 550505). This missense change has been observed in individuals with Pendred syndrome or non-syndromic deafness (PMID: 11932316, 19287372, 24949729, 25394566, 25491636, 27573290). This variant is present in population databases (rs768471577, gnomAD 0.06%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 446 of the SLC26A4 protein (p.Gln446Arg). -
Hearing loss, autosomal recessive Pathogenic:1
- -
Pendred syndrome;C3538946:Autosomal recessive nonsyndromic hearing loss 4 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at